Hematologic Adverse Event Grading
Hematologic Adverse Event Grading is a standardized clinical assessment metric that classifies the severity of blood-related adverse reactions to therapeutic interventions according to predefined hematologic laboratory and clinical criteria.
18
Publications
882
Citations
176
Authors
103
Institutions
Publications per year
2017–2026
7
18
Risk Factors for Thrombocytopenia in Adult Chinese Patients Receiving Linezolid Therapy
Chao Chen, Dai‐Hong Guo, Xiutang Cao et al. · Current Therapeutic Research · 2012 · 70 citations · Full text
Medicine, Hematology, Pharmacology +13
1–5 of 18
176
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 176
103
Inserm
Paris, France
3 h-index
5 publications
478 citations
Feinstein Institute for Medical Research
Manhasset, United States
2 h-index
2 publications
74 citations
Emory University
Atlanta, United States
2 h-index
3 publications
198 citations
University of Oxford
Oxford, United Kingdom
2 h-index
8 publications
598 citations
Heidelberg University
Heidelberg, Germany
2 h-index
4 publications
223 citations
Ludwig-Maximilians-Universität München
Munich, Germany
2 h-index
5 publications
317 citations

LMU Klinikum
Munich, Germany
2 h-index
5 publications
317 citations
Moffitt Cancer Center
Tampa, United States
2 h-index
5 publications
292 citations
1–8 of 103
CTR · 1 publications · 70 citations
1
h-index
1 publications · 69 citations
1
h-index
1 publications · 11 citations
1
h-index
1 publications · 23 citations
1
h-index
1 publications · 14 citations
1
h-index
1–5